Back
Colony Bankcorp, Inc. 10K Form
Buy
62
CBAN
Colony Bankcorp, Inc.
Last Price:
$17.30
Seasonality Move:
-0.92%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | CBAN/Colony Bankcorp, Inc. Quarterly |
| 2023-11-08 | 10Q | CBAN/Colony Bankcorp, Inc. Quarterly |
| 2023-08-09 | 10Q | CBAN/Colony Bankcorp, Inc. Quarterly |
| 2023-05-10 | 10Q | CBAN/Colony Bankcorp, Inc. Quarterly |
| 2022-11-10 | 10Q | CBAN/Colony Bankcorp, Inc. Quarterly |
| 2022-08-12 | 10Q | CBAN/Colony Bankcorp, Inc. Quarterly |
Receive CBAN News And Ratings
See the #1 stock for the next 7 days that we like better than CBAN
CBAN Financial Statistics
Sales & Book Value
| Annual Sales: | $176.8M |
|---|---|
| Cash Flow: | $14.1M |
| Price / Cash Flow: | 6.02 |
| Annual Sales: | $17.31 |
| Price / Book: | 1 |
Profitability
| EPS (TTM): | 1.59200 |
|---|---|
| Net Income (TTM): | $27.8M |
| Gross Margin: | $0 |
| Return on Equity: | 9.68% |
| Return on Assets: | 0.89% |
Colony Bankcorp, Inc. Earnings Forecast
Key Colony Bankcorp, Inc. Financial Ratios
-
The Gross Profit Margin over the past 4 years for CBAN is 0.00%.
-
The Selling, General & Administrative Expenses for CBAN have been equal to 0.00% of Gross Profit Margin.
-
The Interest Expense is 46.75% of Operating Income.
-
The Net Earning history of CBAN is 13.50% of Total Revenues.
-
Per Share Earnings over the last 30 years have been positive in 23 years.
Colony Bankcorp, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Banks |
| Sector: | Financials |
| Current Symbol: | CBAN |
| CUSIP: | 19623P |
| Website: | colony.bank |
Debt
| Debt-to-Equity Ratio: | 0.82 |
|---|---|
| Current Ratio: | 0.16 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 12.76 |
|---|---|
| Forward P/E Ratio: | 8.22 |
CBAN Technical Analysis vs Fundamental Analysis
Buy
62
Colony Bankcorp, Inc. (CBAN)
is a Buy
Is Colony Bankcorp, Inc. a Buy or a Sell?
-
Colony Bankcorp, Inc. stock is rated a BuyThe current Colony Bankcorp, Inc. [CBAN] share price is $17.35. The Score for CBAN is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.